Safety Evaluation of Recombinant Human Interleukin-4 I. Preclinical Studies

By Leach M.W.   Snyder E.A.   Sinha D.P.   Rosenblum I.Y.  

Clinical Immunology, Vol. 83, Iss. 1, 1997-04 ,pp. : 8-11

Academic Press

Access to resources Recommend Favorite

Immunogenicity of Recombinant Human Interleukin-3

By Gunn H.  

Clinical Immunology, Vol. 83, Iss. 1, 1997-04 ,pp. : 5-7

Academic Press

Access to resources Recommend Favorite

Prevention of Murine Experimental Autoimmune Orchitis by Recombinant Human Interleukin-6

By Li L.   Itoh M.   Ablake M.   Macrì B.   Bendtzen K.   Nicoletti F.  

Clinical Immunology, Vol. 102, Iss. 2, 2002-02 ,pp. : 135-137

Academic Press

Access to resources Recommend Favorite

Clinical veterinarian’s perspective of non-human primate (NHP) use in drug safety studies

By Taylor Katrina  

Journal of Immunotoxicology, Vol. 7, Iss. 2, 2010-06 ,pp. : 114-119

Informa Healthcare

Access to resources Recommend Favorite

In Vitro and In Vivo Gene Transfer in the Rat: Characterization of Recombinant Adenoviral Vectors for Rat Interleukin-4 or Interleukin-10 cDNA

By David A.   Cassard A.   Tesson L.   Blancho G.   Sigalla J.   Charreau B.   Godfrin Y.   Smit H.   Le Mauff B.   Soulillou J.-P.   Anegon I.  

Transplantation Proceedings, Vol. 29, Iss. 3, 1997-05 ,pp. : 1750-1751

Elsevier

Access to resources Recommend Favorite